148 related articles for article (PubMed ID: 22351478)
1. Long-term postoperative follow-up in patients with apparently benign pheochromocytoma and paraganglioma.
Amar L; Fassnacht M; Gimenez-Roqueplo AP; Januszewicz A; Prejbisz A; Timmers H; Plouin PF
Horm Metab Res; 2012 May; 44(5):385-9. PubMed ID: 22351478
[TBL] [Abstract][Full Text] [Related]
2. Changes in urinary total metanephrine excretion in recurrent and malignant pheochromocytomas and secreting paragangliomas.
Amar L; Peyrard S; Rossignol P; Zinzindohoue F; Gimenez-Roqueplo AP; Plouin PF
Ann N Y Acad Sci; 2006 Aug; 1073():383-91. PubMed ID: 17102107
[TBL] [Abstract][Full Text] [Related]
3. Perioperative management of pheochromocytoma/paraganglioma: is there a state of the art?
Mannelli M; Dralle H; Lenders JW
Horm Metab Res; 2012 May; 44(5):373-8. PubMed ID: 22517559
[TBL] [Abstract][Full Text] [Related]
4. Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center.
Pham TH; Moir C; Thompson GB; Zarroug AE; Hamner CE; Farley D; van Heerden J; Lteif AN; Young WF
Pediatrics; 2006 Sep; 118(3):1109-17. PubMed ID: 16951005
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of a large series of patients surgically treated for pheochromocytoma.
Khorram-Manesh A; Ahlman H; Nilsson O; Friberg P; Odén A; Stenström G; Hansson G; Stenquist O; Wängberg B; Tisell LE; Jansson S
J Intern Med; 2005 Jul; 258(1):55-66. PubMed ID: 15953133
[TBL] [Abstract][Full Text] [Related]
6. MANAGEMENT OF ENDOCRINE DISEASE: Recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis.
Amar L; Lussey-Lepoutre C; Lenders JW; Djadi-Prat J; Plouin PF; Steichen O
Eur J Endocrinol; 2016 Oct; 175(4):R135-45. PubMed ID: 27080352
[TBL] [Abstract][Full Text] [Related]
7. Unilateral and bilateral adrenalectomy for pheochromocytoma requires adjustment of urinary and plasma metanephrine reference ranges.
Osinga TE; van den Eijnden MH; Kema IP; Kerstens MN; Dullaart RP; de Jong WH; Sluiter WJ; Links TP; van der Horst-Schrivers AN
J Clin Endocrinol Metab; 2013 Mar; 98(3):1076-83. PubMed ID: 23365125
[TBL] [Abstract][Full Text] [Related]
8. Metastases but not cardiovascular mortality reduces life expectancy following surgical resection of apparently benign pheochromocytoma.
Timmers HJ; Brouwers FM; Hermus AR; Sweep FC; Verhofstad AA; Verbeek AL; Pacak K; Lenders JW
Endocr Relat Cancer; 2008 Dec; 15(4):1127-33. PubMed ID: 18824558
[TBL] [Abstract][Full Text] [Related]
9. Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s).
van Heerden JA; Roland CF; Carney JA; Sheps SG; Grant CS
World J Surg; 1990; 14(3):325-9. PubMed ID: 1973322
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic resection of periadrenal paraganglioma in a patient with multiple endocrine neoplasia type 2A.
Nomura T; Takahashi M; Ando T; Sato F; Fujii S; Mimata H
Surg Laparosc Endosc Percutan Tech; 2011 Feb; 21(1):e31-3. PubMed ID: 21304370
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and surgical treatment of extra-adrenal pheochromocytoma].
Hiller WF; Scheumann GF; Dralle H
Chirurg; 1993 Jan; 64(1):36-42. PubMed ID: 8436047
[TBL] [Abstract][Full Text] [Related]
12. Biochemical Testing After Pheochromocytoma Removal: How Early?
Zelinka T; Petrák O; Hamplová B; Turková H; Waldauf P; Rosa J; Šomlóová Z; Holaj R; Štrauch B; Indra T; Kršek M; Brabcová Vránková A; Musil Z; Dušková J; Kubinyi J; Michalský D; Novák K; Widimský J
Horm Metab Res; 2015 Aug; 47(9):633-6. PubMed ID: 26177121
[TBL] [Abstract][Full Text] [Related]
13. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma.
Amar L; Servais A; Gimenez-Roqueplo AP; Zinzindohoue F; Chatellier G; Plouin PF
J Clin Endocrinol Metab; 2005 Apr; 90(4):2110-6. PubMed ID: 15644401
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal implantation of pheochromocytoma following tumor capsule rupture during surgery.
Rafat C; Zinzindohoue F; Hernigou A; Hignette C; Favier J; Tenenbaum F; Gimenez-Roqueplo AP; Plouin PF; Amar L
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2681-5. PubMed ID: 25188716
[TBL] [Abstract][Full Text] [Related]
15. Oncologic aspects of pheochromocytoma: the importance of follow-up.
Scott HW; Halter SA
Surgery; 1984 Dec; 96(6):1061-6. PubMed ID: 6505959
[TBL] [Abstract][Full Text] [Related]
16. Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma.
Koh JM; Ahn SH; Kim H; Kim BJ; Sung TY; Kim YH; Hong SJ; Song DE; Lee SH
PLoS One; 2017; 12(11):e0187398. PubMed ID: 29117221
[TBL] [Abstract][Full Text] [Related]
17. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
[TBL] [Abstract][Full Text] [Related]
18. Surgical Treatment of Malignant Pheochromocytoma and Paraganglioma: Retrospective Case Series.
Strajina V; Dy BM; Farley DR; Richards ML; McKenzie TJ; Bible KC; Que FG; Nagorney DM; Young WF; Thompson GB
Ann Surg Oncol; 2017 Jun; 24(6):1546-1550. PubMed ID: 28058556
[TBL] [Abstract][Full Text] [Related]
19. [Can pheochromocytoma be considered a benign unilateral intra-adrenal sporadic hypertensive tumor ? Reflections on a series of 105 surgically treated subdiaphragmatic chromaffin tumors].
Proye C; Vix M; Goropoulos A; Carnaille B; Vermesse B; Kerlo P; Lecomte-Houcke M
Chirurgie; 1992; 118(8):433-8. PubMed ID: 1343986
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute.
Huang KH; Chung SD; Chen SC; Chueh SC; Pu YS; Lai MK; Lin WC
Int J Urol; 2007 Mar; 14(3):181-5. PubMed ID: 17430251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
